Rajendrabose Deivanes, Collet Lucie, Reinaud Camille, Beydon Maxime, Jiang Xiaojun, Hmissi Sahra, Vermillac Antonin, Degonzague Thomas, Hajage David, Dechartres Agnès
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie de l'AP-HP (Cephepi), Paris, France.
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie de l'AP-HP (Cephepi), Paris, France.
J Clin Epidemiol. 2025 Jan;177:111613. doi: 10.1016/j.jclinepi.2024.111613. Epub 2024 Nov 16.
Many negative randomized controlled trials (RCTs) report spin in their conclusions to highlight the benefits of the experimental arm, which could correspond to a noninferiority (NI) objective. We aimed to evaluate whether some negative superiority RCTs comparing 2 active interventions could correspond to an NI situation and to explore associated trial characteristics.
We searched PubMed for superiority RCTs comparing 2 active interventions with non-statistically significant results for the primary outcome that were published in 2021 in the 5 journals with the highest impact factor in each medical specialty. Three reviewers independently evaluated whether trials could correspond to an NI situation (ie, an evaluation of efficacy as the primary outcome, with the experimental intervention presenting advantages including better safety profile, ease of administration, or decreased cost as compared with the control intervention).
Of the 147 trials included, 19 (12.9%, 95% CI [7.9%, 19.4%]) corresponded to a potential NI situation. As compared with trials not in a potential NI situation, they were published in a journal with a lower impact factor (median impact factor 8.7 vs 15.6), were more frequently rated at high or some concerns regarding risk of bias (n = 14, 73.7% vs n = 69, 53.9%) and reported spin in the article conclusions (n = 11, 57.9% vs n = 24, 18.8%).
A non-negligible proportion of superiority negative trials comparing 2 active interventions could correspond to an NI situation. These trials seemed at increased risk of bias and frequently reported spin in the conclusions, which may distort the interpretation of results.
Noninferiority trials are designed to show that a new intervention is not worse in terms of efficacy than the reference intervention. It is adapted when the new intervention has an advantage in terms of safety, ease of use or cost over the reference one. However, the literature displayed some superiority negative trials comparing 2 active interventions that could correspond to a potential noninferiority situation. Our study aimed to assess whether some superiority trials with nonsignificant results for the primary outcome could correspond to an NI situation and to explore associated trial characteristics. Our findings indicate that a non-negligible proportion of superiority negative trials could correspond to a noninferiority situation. Moreover, those trials seemed at increased risk of bias and frequently reported spin in the conclusions.
许多阴性随机对照试验(RCT)在其结论中存在结果扭曲,以突出试验组的益处,这可能符合非劣效性(NI)目标。我们旨在评估一些比较两种活性干预措施的阴性优效性RCT是否可能符合NI情况,并探索相关的试验特征。
我们在PubMed中检索了2021年发表在各医学专业影响因子最高的5种期刊上的、比较两种活性干预措施且主要结局无统计学显著结果的优效性RCT。三位评审员独立评估试验是否可能符合NI情况(即,将疗效评估作为主要结局,试验干预措施相较于对照干预措施具有优势,包括更好的安全性、更易给药或成本降低)。
在纳入的147项试验中,19项(12.9%,95%置信区间[7.9%,19.4%])符合潜在的NI情况。与非潜在NI情况的试验相比,它们发表在影响因子较低的期刊上(中位影响因子8.7对15.6),在高偏倚风险或存在一些偏倚风险方面的评级更频繁(n = 14,73.7%对n = 69,53.9%),并且在文章结论中存在结果扭曲(n = 11,57.9%对n = 24,18.8%)。
比较两种活性干预措施的优效性阴性试验中有不可忽视的比例可能符合NI情况。这些试验似乎存在更高的偏倚风险,并且在结论中经常存在结果扭曲,这可能会扭曲对结果的解释。
非劣效性试验旨在表明一种新干预措施在疗效方面不比对照干预措施差。当新干预措施在安全性、易用性或成本方面优于对照干预措施时适用。然而,文献中显示一些比较两种活性干预措施的优效性阴性试验可能符合潜在的非劣效性情况。我们的研究旨在评估一些主要结局无显著结果的优效性试验是否可能符合NI情况,并探索相关的试验特征。我们的研究结果表明,优效性阴性试验中有不可忽视的比例可能符合非劣效性情况。此外,这些试验似乎存在更高的偏倚风险,并且在结论中经常存在结果扭曲。